Michael Goodyear - Concepedia

Author

Michael Goodyear

Also Known As

M D E Goodyear, M D Goodyear, M Goodyear, M. D E Goodyear, M. D. E. GOODYEAR, M. D. E. Goodyear, M. D. GOODYEAR, M. D. Goodyear, M. Goodyear, M.D. Goodyear

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

Dalhousie University Ottawa Regional Cancer Foundation McMaster University Western University Washington University in St. Louis

About

Michael Goodyear is an author at Dalhousie University specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	2.1K
2	Health Sciences	5	5	382
3	Natural Sciences	5	5	121
4	Engineering	2	2	57
5	Nursing	1	1	225

Michael Goodyear

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Carcinoma of the Anal Canal Lisa A. Kachnic, Kathryn Winter, Robert J. Myerson, International Journal of Radiation OncologyBiologyPhysics Surgical OncologyRadiation MedicineRadiation TherapyMedicineSurgery	2012	606
The Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast Cancer Mark N. Levine, Michael Gent, J. Hirsh, New England Journal of Medicine Breast OncologyAnticancer Drug TherapyMedicineCancer ManagementThromboembolic Disease	1988	417
Randomized Placebo-Controlled Study of Low-Dose Warfarin for the Prevention of Central Venous Catheter–Associated Thrombosis in Patients With Cancer Stephen Couban, Michael Goodyear, Margot J. Burnell, Journal of Clinical Oncology	2005	328
Applications of dose intensity to problems in chemotherapy of breast and colorectal cancer. W M Hryniuk, A Figueredo, Michael Goodyear PubMed	1987	231
Quality of life in stage II breast cancer: an instrument for clinical trials. Mark N. Levine, Gordon Guyatt, Michael Gent, Journal of Clinical Oncology Quality Of LifeLife AssessmentBreast OncologyCancer ManagementAdjuvant Chemotherapy	1988	225
The Relationship between Anti-Factor Xa Level and Clinical Outcome in Patients Receiving Enoxaparine Low Molecular Weight Heparin to Prevent Deep Vein Thrombosis after Hip Replacement Mark N. Levine, A. Planès, J. Hirsh, Thrombosis and Haemostasis Deep Vein ThrombosisPharmacotherapySurgeryExperimental AnimalsOsteoporosis	1989	214
Good Outcome Associated with a Standardized Treatment Protocol Using Selective Postoperative Radiation in Patients with Clinical Stage I Adenocarcinoma of the Endometrium Mark Carey, Curtis R. Johanson, Michael Goodyear, Gynecologic Oncology Clinical StageSurgical OncologyRadiation TherapyMedicineBrachytherapy	1995	163
Sleep habits of healthy young adults: use of a sleep questionnaire. Murray W. Johns, Tricia Gay, Michael Goodyear, Journal of Epidemiology & Community Health Sleep DisordersSleep HealthNeuropsychologyUsual SleepHealthy Young Adults	1971	58
Diastereoselective Synthesis of the Potent Antiviral Agent (-)-2'-Deoxy-3'-thiacytidine and Its Enantiomer Haolun Jin, M. Arshad Siddiqui, Colleen A. Evans, The Journal of Organic Chemistry Medicinal ChemistryEnantioselective SynthesisMedicineAntiviral Drug DevelopmentAltmetric Attention Score	1995	57
Comparison of the addition of T and N integer scores with TNM stage groups in head and neck cancer Glenn Jones, George P. Browman, Michael Goodyear, Head & Neck	1993	55

Page 1